61703-304 : Cytarabine 20 mg/ml Intravenous; Subcutaneous Solution


NDC: 61703-304
Labeler: Hospira Worldwide, Inc.
Product Type: Human Prescription Drug
Drug Name: Cytarabine
Dosage Form: Intravenous; Subcutaneous Solution
Application #: ANDA072945
Rev. Date: 


NDC Package Codes:

  • 61703-304-36: 1 VIAL, MULTI‑DOSE IN 1 CARTON (61703‑304‑36) > 25 ML IN 1 VIAL, MULTI‑DOSE

Active Ingredients:

  • Cytarabine

Dosage Strength:

  • 20 mg/mL

Pharmaceutical Classes:

  • Nucleic Acid Synthesis Inhibitors [MoA]
  • Nucleoside Metabolic Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 61703-303 Cytarabine 20 mg/ml Intravenous Injection, Solution by Hospira Worldwide, Inc.
  • 61703-305 Cytarabine 20 mg/ml Intrathecal; Intravenous; Subcutaneous Injection, Solution by Hospira Worldwide, Inc.
  • 61703-319 Cytarabine 100 mg/ml Intrathecal; Intravenous; Subcutaneous Injection, Solution by Hospira Worldwide, Inc.
  • 0069-0152 Cytarabine 100 mg/5ml Intrathecal; Intravenous; Subcutaneous Injection by Pfizer Laboratories Div Pfizer Inc.
  • 0069-0153 Cytarabine 20 mg/ml Intravenous; Subcutaneous Injection by Pfizer Laboratories Div Pfizer Inc.
  • 0069-0154 Cytarabine 20 mg/ml Intravenous; Subcutaneous Injection by Pfizer Laboratories Div Pfizer Inc.
  • 0069-0155 Cytarabine 2 g/20ml Intrathecal; Intravenous; Subcutaneous Injection by Pfizer Laboratories Div Pfizer Inc.
  • 25021-223 Cytarabine 100 mg/ml Intrathecal; Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
  • 25021-229 Cytarabine 20 mg/ml Intrathecal; Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
  • 55390-131 Cytarabine 100 mg/5ml Intrathecal; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 55390-132 Cytarabine 500 mg/10ml Intrathecal; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 55390-133 Cytarabine 1 g/10ml Intrathecal; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 55390-134 Cytarabine 2 g/20ml Intrathecal; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 55390-806 Cytarabine 100 mg/5ml Intrathecal; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 55390-807 Cytarabine 500 mg/10ml Intrathecal; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 55390-808 Cytarabine 1 g/10ml Intrathecal; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 55390-809 Cytarabine 2 g/20ml Intrathecal; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 63323-120 Cytarabine 100 mg/ml Intrathecal; Intravenous; Subcutaneous Injection, Solution by App Pharmaceuticals, LLC
  • 67457-452 Cytarabine 2 g/20ml Intrathecal; Intravenous; Subcutaneous Injection by Mylan Institutional LLC
  • 67457-454 Cytarabine 20 mg/ml Intravenous; Subcutaneous Injection by Mylan Institutional LLC
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 61703-304 QR Code

< Prev: 61703-303Next: 61703-305 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.